Ticker Scorecard - HRMY Basics Company: Harmony Biosciences Holdings, Inc. IPO Date: August 19, 2020 Sector: Healthcare Industry: Biotech Market Cap: $1.97B Activated in VL: True Average Daily Range Avg Daily Range: $0.82 | 2.17% Avg Daily Range (30 D): $0.55 | 1.46% Avg Daily Range (90 D): $0.59 | 1.65% Institutional Daily Volume Avg Daily Volume: .39M Avg Daily Volume (30 D): .47M Avg Daily Volume (90 D): .52M Trade Size Avg Trade Size (Sh.): 54 Avg Trade Size (Sh.) (30 D): 48 Avg Trade Size (Sh.) (90 D): 53 Institutional Trades Total Inst.Trades: 1,693 Avg Inst. Trade: $2.2M Avg Inst. Trade (30 D): $2.52M Avg Inst. Trade (90 D): $2.81M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.66M Avg Closing Trade (30 D): $2.95M Avg Closing Trade (90 D): $3.87M Avg Closing Volume: 71.52K     News Jan 22, 2025 @ 6:00 PM 5-HT2 Agonist Clinical Trial Pipeline Appears Robu... Source: Delveinsight Dec 19, 2024 @ 6:00 PM Comprehensive Market Analysis of Latest Published ... Source: Delveinsight Oct 14, 2024 @ 2:46 PM Dravet Syndrome Drug Pipeline Research Report 2024... Source: Researchandmarkets.Com Aug 6, 2024 @ 12:45 PM Harmony Biosciences Holdings, Inc. (HRMY) Surpasse... Source: Zacks.Com Jun 21, 2024 @ 7:32 AM Praxis Precision Medicines (PRAX) Surges 6.4%: Is ... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $2.15 $.81 $.2 Diluted EPS $2.11 $.79 $.2 Revenue $ 681.88M $ 186.04M $ 172.81M Gross Profit $ 536.32M $ 143.26M $ 140.67M Net Income / Loss $ 122.63M $ 46.09M $ 11.59M Operating Income / Loss $ 175.3M $ 61.71M $ 21.36M Cost of Revenue $ 145.56M $ 42.78M $ 32.14M Net Cash Flow $ 62.78M $ 70.07M $ -15.69M PE Ratio 0.00